Yahoo Web Search

Search results

  1. Ken Anderson, MD, on Therapeutic Advances in Multiple Myeloma. Dr. Ken Anderson gives a comprehensive update on research and treatment of multiple myeloma, including new advances presented at the American Society of Hematology Annual Meeting in 2022.

  2. Harvard Medical School, Dana-Farber Cancer Institute. Dr. Ken Anderson is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute.

  3. Nov 29, 2012 · Updated: June 2, 2022. When Ken Anderson, MD, began working on multiple myeloma four decades ago, the disease, a cancer of the bone marrow, was untreatable. “People died within months,” says Anderson. Today, the story is very different. In the past decade, eight new multiple myeloma treatments have been approved. Survival has doubled.

    • Dana-Farber
  4. Ken Anderson, MD 05:38 In myeloma, there is one clone of cells that produces one abnormal clone of protein. Ken Shulman 05:46 That's Ken Anderson. He directs the Jerome Lipper Multiple Myeloma Center and Lebow Institute for Myeloma Therapeutics at Dana-Farber. Ken Anderson, MD 05:55

  5. Dr. Kenneth Anderson is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute.

  6. The American Society of Clinical Oncology (ASCO) has named Dana-Farber Cancer Institute's Ken Anderson, MD, its 2011 David A. Karnofsky Memorial Award and Lecture honoree for his outstanding achievements in cancer research and patient treatment.

  7. www.dfhcc.harvard.edu › insider › member-detailMember Detail - DF/HCC

    Kenneth C. Anderson, MD. Dana-Farber Cancer Institute. EDUCATIONAL TITLES. Kraft Family Professor of Medicine, Medicine, Harvard Medical School. Physician, Oncology, Brigham And Women's Hospital. DF/HCC PROGRAM AFFILIATION. Lymphoma and Myeloma, Member. Research Abstract. Our laboratory efforts focus on translational research in multiple myeloma.

  1. People also search for